LOPREIATO, Mariangela
 Distribuzione geografica
Continente #
EU - Europa 103
NA - Nord America 52
AS - Asia 20
SA - Sud America 3
AF - Africa 1
Totale 179
Nazione #
IT - Italia 66
US - Stati Uniti d'America 50
SG - Singapore 16
DE - Germania 14
FI - Finlandia 7
GB - Regno Unito 6
NL - Olanda 5
BR - Brasile 3
FR - Francia 2
IN - India 2
RU - Federazione Russa 2
CA - Canada 1
CN - Cina 1
ES - Italia 1
HK - Hong Kong 1
TT - Trinidad e Tobago 1
ZA - Sudafrica 1
Totale 179
Città #
Carbonia 12
Munich 10
Singapore 8
Chicago 6
London 5
Ashburn 4
Chandler 4
Ercolano 4
Turku 4
Afragola 3
Helsinki 3
Los Angeles 3
Rome 3
Santa Clara 3
Bologna 2
Brescia 2
Frankfurt am Main 2
New York 2
Paris 2
Reggio Calabria 2
San Nicola Manfredi 2
Ahmedabad 1
Alvorada 1
Arnhem 1
Benevento 1
Brooklyn 1
Buffalo 1
Catanzaro 1
Chaguanas 1
Charlotte 1
Cosenza 1
Crestview 1
Hanover 1
Hong Kong 1
Hyderabad 1
Johannesburg 1
Manchester 1
Melito di Porto Salvo 1
Milan 1
Naples 1
Norwich 1
Nuremberg 1
Palermo 1
Parma 1
Santo Stefano di Rogliano 1
Sorrento 1
Soverato Marina 1
Squillace 1
St Petersburg 1
São Paulo 1
Ubá 1
Washington 1
Totale 117
Nome #
A Novel Bispecific T-Cell Engager (CD1a x CD3ε) BTCE Is Effective against Cortical-Derived T Cell Acute Lymphoblastic Leukemia (T-ALL) Cells 85
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 78
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 24
Totale 187
Categoria #
all - tutte 1.063
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.063


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202325 6 3 0 1 1 0 1 3 3 0 7 0
2023/202449 15 6 6 2 1 6 4 1 0 2 3 3
2024/2025111 11 2 2 5 5 12 6 5 9 2 25 27
2025/20262 2 0 0 0 0 0 0 0 0 0 0 0
Totale 187